ORIGINAL RESEARCH

Takayasu's arteritis: the retrospective analysis of patients from the Ural population

Borodina IE1,2, Popov AA2, Salavatova GG1, Shardina LA2
About authors

1 Sverdlovsk Regional Clinical Hospital No.1, Yekaterinburg, Russia

2 Ural State Medical University, Yekaterinburg, Russia

Correspondence should be addressed: Irina E. Borodina
Repina 3, Yekaterinburg, Sverdlovsk region, 620014; ur.liam@kisydorob

About paper

Author contribution: all authors participated in conceiving and planning the study, processing the data, discussing the results, and writing the manuscript. Borodina IE and Salavatova GG collected the medical records for the electronic database.

Received: 2018-08-10 Accepted: 2019-03-02 Published online: 2019-03-14
|
Fig. 1. Survival of the patients with TA
Table 1. Characteristics of the patients with Takayasu's arteritis included in the study
Table 2. Clinical and laboratory findings
Note: Me — median; 25% — the lower quartile; 75% — the upper quartile.
Table 3. Arterial damage in the patients with TA (the present study)
Table 4. Surgical interventions performed in the patients with TA
Note: AFBG — aorto-femoral bypass grafting; AMCB — aorto- and mammary coronary bypass; BCA — brachiocephalic artery; SFA — superficial femoral artery; DFA — deep femoral artery.
Table 5. Medication therapy received by the patients with Takayasu arteriitis
Table 6. Causes of death in the patients with TA
Note: PE — pulmonary embolism.
Table 7. Cardiovascular complications in patients with TA
Table 8. Clinical symptoms of TA in different geographical regions
Table 9. Arteries affected by the pathology in patients with TA residing in different geographical regions
Table 10. Damage to the arteries in patients with TA representing the Russian population
Table 11. Angiographic characteristics of TA in different regions across the world